Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
Valencia, Spain
Dr. Andrés Cervantes is Head of the Medical Oncology Department at the University Hospital of Valencia. His training as a Resident Internal Physician was carried out at the same hospital. After completing this period he obtained a predoctoral fellowship at the Free University Hospital in Amsterdam, where he obtained his Doctorate in the cell pharmacology laboratory, with research on resistance to multiple drugs.
Dr. Cervantes is Professor of Medicine at the University of Valencia. Since May 2017 he is the Scientific Director of the Institute of Biomedical Research - INCLIVA.
His main areas of interest and research are gastrointestinal and gynecological cancer, phase I trials and development of new drugs. He is a clinical researcher on rectal cancer, a subject in which he has developed several publications on multidisciplinary work, the evaluation of the quality of mesorectal surgery, the optimization of the choice of initial therapy and how to treat cancer of the upper third of the rectum. He currently works in the role of liquid biopsy as a marker of minimal residual disease in colon cancer.
He is the author of more than 300 articles published in peer-reviewed journals. He is editor of the journal Cancer Treatment Reviews. He has been director of Education at ESMO, European Society of Medical Oncology and associate editor of the Annals of Oncology, the European medical Journal with the highest impact on oncology. He is currently President Elect of ESMO.
Wednesday, June 29, 2022
16:15 – 17:00
Thursday, June 30, 2022
08:00 – 08:45
Thursday, June 30, 2022
08:30 – 08:45
Thursday, June 30, 2022
09:15 – 09:25
Thursday, June 30, 2022
10:00 – 12:50
Thursday, June 30, 2022
10:54 – 11:04